Based on the above, this retrospective monocentric observational study aimed to estimate the prevalence and severity of metabolic comorbidities (diabetes, hypertension, and dyslipidemia) in surgically treated acromegalic patients with disease control and concordant or discordant GH/IGF-1 levels. The gene discussed is IGF1; the disease is diabetes mellitus.